Literature DB >> 15227462

All ACTs are not created equal.

J J Ferguson.   

Abstract

Year:  1992        PMID： 15227462      PMCID： PMC325009     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN： 0730-2347


× No keyword cloud information.
  10 in total

1.  Use of the activated coagulation time in intraoperative heparin reversal for cardiopulmonary operations.

Authors:  K L Mattox; G A Guinn; P A Rubio; A C Beall
Journal:  Ann Thorac Surg       Date:  1975-06       Impact factor: 4.330

2.  Statistical correlation and heparin sensitivity of activated partial thromboplastin time, whole blood coagulation time, and an automated coagulation time.

Authors:  H G Schriever; S E Epstein; M D Mintz
Journal:  Am J Clin Pathol       Date:  1973-09       Impact factor: 2.493

3.  A simple method of heparin management during prolonged extracorporeal circulation.

Authors:  J D Hill; L Dontigny; M De Leval; C H Mielke
Journal:  Ann Thorac Surg       Date:  1974-02       Impact factor: 4.330

4.  Monitoring of intraoperative heparinization and blood loss following cardiopulmonary bypass surgery.

Authors:  R Babka; C Colby; A El-Etr; R Pifarré
Journal:  J Thorac Cardiovasc Surg       Date:  1977-05       Impact factor: 5.209

5.  Activated coagulation time of whole blood.

Authors:  P G Hattersley
Journal:  JAMA       Date:  1966-05-02       Impact factor: 56.272

6.  Monitoring the effect of heparin by measurement of activated clotting time during and after percutaneous transluminal coronary angioplasty.

Authors:  B Rath; D H Bennett
Journal:  Br Heart J       Date:  1990-01

7.  Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage.

Authors:  B S Bull; W M Huse; F S Brauer; R A Korpman
Journal:  J Thorac Cardiovasc Surg       Date:  1975-05       Impact factor: 5.209

8.  Heparin therapy during extracorporeal circulation. I. Problems inherent in existing heparin protocols.

Authors:  B S Bull; R A Korpman; W M Huse; B D Briggs
Journal:  J Thorac Cardiovasc Surg       Date:  1975-05       Impact factor: 5.209

9.  Adequate heparinization during PTCA: assessment using activated clotting times.

Authors:  J D Ogilby; H A Kopelman; L W Klein; J B Agarwal
Journal:  Cathet Cardiovasc Diagn       Date:  1989-12

10.  The role of the activated clotting time in heparin administration and neutralization for cardiopulmonary bypass.

Authors:  R A Esposito; A T Culliford; S B Colvin; S J Thomas; H Lackner; F C Spencer
Journal:  J Thorac Cardiovasc Surg       Date:  1983-02       Impact factor: 5.209
  10 in total
  3 in total

Review 1.  Management and monitoring of anticoagulation for children undergoing cardiopulmonary bypass in cardiac surgery.

Authors:  Colleen E Gruenwald; Cedric Manlhiot; Lynn Crawford-Lean; Celeste Foreman; Leonardo R Brandão; Brian W McCrindle; Helen Holtby; Ross Richards; Helen Moriarty; Glen Van Arsdell; Anthony K Chan
Journal:  J Extra Corpor Technol       Date:  2010-03

Review 2.  Use of the activated clotting time in anticoagulation monitoring of intravascular procedures.

Authors:  J Bowers; J J Ferguson
Journal:  Tex Heart Inst J       Date:  1993

Review 3.  Heparin dose during percutaneous coronary intervention: how low dare we go?

Authors:  G Niccoli; A P Banning
Journal:  Heart       Date:  2002-10       Impact factor: 5.994
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.